Team Lifestyle Immersion Hypertension Control Project

NCT ID: NCT07201948

Last Updated: 2025-10-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-01

Study Completion Date

2028-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project is focuses on reducing the risk and progression of hypertension among a population that records high incidence of hypertension and other chronic ailments such as heart disease, diabetes, kidney failure, and obesity, with similar control measures. Several clinical trials over the last five decades have emphasized the importance of supportive lifestyle modification in the control of chronic disease that include a healthy diet, physical activity, quitting tobacco use, reducing alcohol use to the minimum, self-management of the disease, and adequate sleep. Study participants will receive motivation and skill development support in additional to specific nutrition, physical fitness, and self-management counselling from certified experts. This intervention incorporates elements of the American Heart Association prescription for health, Life's Simple 7 (LS7) lifestyle modification, the Dietary Approaches to preventing Hypertension (DASH) eating plan.

After receiving these interventions, participants will be contacted at 3-months, 6-months, and 12-months for follow-up. They will complete similar surveys to be compared to determine impact on their hypertension.

This intervention is complementary to usual pharmaceutical hypertension management.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

African Americans continue to bear disproportionate chronic disease morbidity and mortality, and tend to report lower benefits from clinical trials that include lifestyle modifications in addition to pharmaceutical management. This project uses hypertension as an index case for other chronic ailments such as heart disease, diabetes, kidney failure, and obesity, especially as their control measures are similar. Several clinical trials over the last five decades have emphasized the importance of supportive lifestyle modification in the control of chronic disease that include a healthy diet, physical activity, quitting tobacco use, reducing alcohol use to the minimum, self-management of the disease, and adequate sleep. Although socioeconomic factors can impact disease management outcomes, African Americans may require additional motivational support to first accept the notion of change of lifestyle and to adhere to the changes that may be a major shift in their eating and exercise habits. The need to positively impact chronic disease, particularly hypertension, morbidity and morbidity in the African American population deserves both pharmaceutical and non-pharmaceutical approaches. This intervention incorporates elements of the American Heart Association prescription for health, Life's Simple 7 (LS7) lifestyle modification, the Dietary Approaches to Stop Hypertension (DASH) eating plan, provides the knowledge and skills necessary for success, and introduces the motivation boost of participating in teams of 4-6 participants. The primary intervention outcome is adherence to the seven elements of LS7, measured by LS7 Scores at enrollment, and at 6- and 12-months follow-up. Secondary outcomes will include changes in SBP/DBP, BMI, Waist girth, and A1C. The study shall compare Team versus Individual study arms for participants recruited and managed in the health center and the home settings separately and combined. Intermediate outcomes will include, and not limited to biomarkers such as urine sodium, serum Plasminogen activator inhibitor-1 (PAI-1) for hypertension, Interleukin 6 (IL6), and C-reactive protein (CRP) for obesity.

The goal is to enroll 220 participants, half from health institutions (Nashville General Hospital \& Mathew Walker Comprehensive Health Center) and the other half from the community (MDHA residence, Health Fairs, Churches etc.). Half of the participants will be people already diagnosed with hypertension (BP 140/90 or higher, or on hypertension medication) and half will be those at increased risk of developing hypertension with BP measurement 130/80 and above.

The study will be implemented in three phases:

Phase 1: Health Behavior Assessment. Phase 2: Intervention Development. Phase 3: Intervention Effectiveness Evaluation.

Intervention:

Participants will complete the study survey and a food frequency questionnaire and enrollment. they will also provide 5ml venous blood sample for biomarker assay. They will complete the same surveys at follow-up at 6- and 12-months to provide data for evaluation effectiveness.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two Study Arms:

1. . Team Group
2. . Individual Group All participants will receive the same intervention, but will be randomized into two study arms.

Team Group: 4-6 participants will be assigned to work on their lifestyle as a team, motivating each other to adhere to the study intervention elements.

Individual Group: Each participant will work on their own to adhere to the study intervention elements.
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Team Group

4-6 participants will be assigned to a Team. They will be instructed to work together and motivate each other to adhere to the intervention components, to attend intervention activities, and meet lifestyle modification goals.

They will receive the intervention knowledge and skills training from:

* Dietician
* Physical Fitness Trainer
* cardiologist They will also receive other support to enhance their lifestyle immersion from the research team.

Group Type ACTIVE_COMPARATOR

Lifestyle Immersion Intervention that will address Nutrition, Physical Fitness, and BP Self-Monitoring3 Elements:

Intervention Type BEHAVIORAL

1. : Two distinct groups will be enrolled:

* Those diagnosed with hypertension: BP \>=140/90, within the last 2 years.
* Those with BP \>=130/80. Not yet diagnosed with hypertension.
2. . Intervention: Comprehensive and integrated intervention components

* Implemented by 3 certified experts (Dietician, Fitness Trainer, Cardiologist)
* Modules: Education, Demonstration, Practical skill development sessions.
3. . Intervention is based on American Hearts Association Life's Simple 7. The nutrition aspect will follow the DASH Diet plan.

Individual Group

Individual participants will be instructed to self-motivate to adhere to the intervention components, to attend intervention activities, and meet lifestyle modification goals.

They will receive the intervention knowledge and skills training from:

* Dietician
* Physical Fitness Trainer
* cardiologist They will also receive other support to enhance their lifestyle immersion from the research team.

Group Type ACTIVE_COMPARATOR

Lifestyle Immersion Intervention that will address Nutrition, Physical Fitness, and BP Self-Monitoring3 Elements:

Intervention Type BEHAVIORAL

1. : Two distinct groups will be enrolled:

* Those diagnosed with hypertension: BP \>=140/90, within the last 2 years.
* Those with BP \>=130/80. Not yet diagnosed with hypertension.
2. . Intervention: Comprehensive and integrated intervention components

* Implemented by 3 certified experts (Dietician, Fitness Trainer, Cardiologist)
* Modules: Education, Demonstration, Practical skill development sessions.
3. . Intervention is based on American Hearts Association Life's Simple 7. The nutrition aspect will follow the DASH Diet plan.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lifestyle Immersion Intervention that will address Nutrition, Physical Fitness, and BP Self-Monitoring3 Elements:

1. : Two distinct groups will be enrolled:

* Those diagnosed with hypertension: BP \>=140/90, within the last 2 years.
* Those with BP \>=130/80. Not yet diagnosed with hypertension.
2. . Intervention: Comprehensive and integrated intervention components

* Implemented by 3 certified experts (Dietician, Fitness Trainer, Cardiologist)
* Modules: Education, Demonstration, Practical skill development sessions.
3. . Intervention is based on American Hearts Association Life's Simple 7. The nutrition aspect will follow the DASH Diet plan.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Life's Simple 7 DASH Diet

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Reside in Davidson and surrounding counties of Tennessee.
* At least 30 years old.
* At increased risk for developing hypertension (already diagnosed or a strong family history).
* Be able to consent.
* Not planning to move from this study area in 12 months after enrollment.

Exclusion Criteria

* Does not reside in Davidson and surrounding counties.
* Less than 30 years old, or older than 80 years.
* Not at assessed increased risk for hypertension.
Minimum Eligible Age

30 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

Sponsor Role collaborator

Meharry Medical College

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Flora Ukoli, MD, MPH

Role: STUDY_DIRECTOR

Meharry Medical College

Stephena Miller-Hughes, Ph.D.

Role: STUDY_DIRECTOR

Meharry Medical College

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Meharry Medical College

Nashville, Tennessee, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Flora Ukoli, MD, MPH

Role: CONTACT

16153275653

Adrian Samuels, Ph.D.

Role: CONTACT

1615-207-8382

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Flora Ukoli, MD, MPH

Role: primary

16153275653

Adrian Samuels, Ph.D.

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5P50MD017347-04

Identifier Type: NIH

Identifier Source: secondary_id

View Link

25-02-1555

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Med-South Lifestyle Study: Phase 1
NCT04421703 COMPLETED NA